| 2024-08-08 | -75.6% | earnings | Seeking Alpha | Outset Medical stock falls as RBC cuts on Q2 miss (NASDAQ:OM) - Seeking Alpha |
| 2024-08-07 | -71.2% | legal | SEC EDGAR | OM 8-K: 2.02 and (SEC Filing) |
| 2023-10-12 | -54.5% | legal | SEC EDGAR | OM 8-K: 2.02 and (SEC Filing) |
| 2025-11-11 | -54.4% | earnings | Seeking Alpha | Outset Medical signals $115M-$120M revenue guidance revision amid sales process transformation and leadership change |
| 2025-11-11 | -54.4% | earnings | Seeking Alpha | Outset Medical, Inc. (OM) Q3 2025 Earnings Call Transcript |
| 2025-11-11 | -54.4% | earnings | MassDevice | Outset Medical stock is down on Q3 sales miss, slashed guidance - MassDevice |
| 2025-11-11 | -54.4% | news | Stocktwits | Why Did Outset Medical Stock Tumble Today? - Stocktwits |
| 2025-11-11 | -54.4% | news | Benzinga | Outset Medical, Gemini Space Station, CoreWeave And Other Big Stocks Moving Lower In Tuesday's Pre-Market - Benzinga |
| 2025-11-11 | -54.4% | analyst | Investing.com | Outset Medical stock falls as BTIG lowers price target to $17 from $19 - Investing.com |
| 2025-11-10 | -50.2% | earnings | Seeking Alpha | Outset Medical Non-GAAP EPS of -$0.69 misses by $0.03, revenue of $29.43M misses by $1.27M |
| 2025-11-10 | -50.2% | legal | SEC EDGAR | OM 8-K: 2.02 and (SEC Filing) |
| 2025-11-10 | -50.2% | earnings | Yahoo Finance | Outset Medical, Inc. (OM) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance |
| 2025-11-10 | -50.2% | earnings | Yahoo Finance | Outset Medical Inc (OM) Q3 2025 Earnings Call Highlights: Navigating Growth and Challenges - Yahoo Finance |
| 2025-11-10 | -50.2% | news | GuruFocus | OM Stock Forecast: Financial Outlook for 2025 - GuruFocus |
| 2025-11-10 | -50.2% | earnings | GuruFocus | Outset Medical (OM) Adjusts 2025 Revenue Forecast Amid Sales Tim - GuruFocus |
| 2023-10-13 | -42.9% | news | AskTraders | Outset Medical (OM) Stock Price Plunges 43.3%, Extending Losses - AskTraders |
| 2025-05-07 | +36.5% | earnings | Seeking Alpha | Outset Medical Non-GAAP EPS of -$3.24 misses by $2.30, revenue of $29.75M beats by $1.94M |
| 2025-05-07 | +36.5% | legal | SEC EDGAR | OM 8-K: 2.02 and (SEC Filing) |
| 2022-06-13 | -31.8% | legal | SEC EDGAR | OM 8-K: 2.02, 8.01 (SEC Filing) |
| 2025-05-08 | +29.8% | earnings | Seeking Alpha | Outset Medical, Inc. (OM) Q1 2025 Earnings Call Transcript |
| 2022-06-14 | -29.7% | news | The Motley Fool | Outset Medical Plunges on Shipment Hold: Buy the Stock on the Sell-Off? - The Motley Fool |
| 2024-05-09 | -26.4% | earnings | MassDevice | Outset Medical stock sinks on workforce reduction, Q1 misses - MassDevice |
| 2024-08-16 | -25.7% | legal | SEC EDGAR | OM 8-K: 5.02 (SEC Filing) |
| 2026-02-12 | -23.9% | earnings | Moby | Outset Medical, Inc. Q4 2025 Earnings Call Summary |
| 2026-02-12 | -23.9% | earnings | GuruFocus.com | Outset Medical Inc (OM) Q4 2025 Earnings Call Highlights: Strategic Advances and Financial ... |
| 2026-02-12 | -23.9% | earnings | Seeking Alpha | Outset Medical outlines 5%–9% revenue growth for 2026 with next-gen Tablo launch and gross margin expansion |
| 2026-02-12 | -23.9% | earnings | Seeking Alpha | Outset Medical, Inc. (OM) Q4 2025 Earnings Call Transcript |
| 2022-08-01 | +22.8% | legal | SEC EDGAR | OM 8-K: 2.02, 8.01 (SEC Filing) |
| 2024-11-07 | +22.5% | earnings | Seeking Alpha | Outset Medical Inc. (OM) Q3 2024 Earnings Call Transcript |
| 2022-11-08 | +21.7% | legal | SEC EDGAR | OM 8-K: 2.02 and (SEC Filing) |
| 2025-01-06 | -20.9% | news | Seeking Alpha | Outset Medical announces $169 million private placement |
| 2025-01-06 | -20.9% | legal | SEC EDGAR | OM 8-K: 1.01, 2.02, 3.02, 7.01 (SEC Filing) |
| 2024-11-06 | +20.5% | legal | SEC EDGAR | OM 8-K: 2.02 and (SEC Filing) |
| 2025-11-12 | -19.6% | earnings | simplywall.st | Could Tablo’s Real-World Success Shift Outset Medical’s (OM) Growth Trajectory Despite Lowered Guidance? - simplywall.st |
| 2025-11-12 | -19.6% | legal | Claim Depot | Outset Medical, Inc. Securities Lawsuit Investigation - Claim Depot |
| 2024-05-06 | +19.6% | legal | SEC EDGAR | OM 8-K: 8.01 and (SEC Filing) |
| 2026-02-11 | -17.6% | earnings | MarketBeat | Outset Medical Q4 Earnings Call Highlights |
| 2026-02-11 | -17.6% | news | GlobeNewswire | Outset Medical Reports Fourth Quarter and Full Year 2025 Financial Results |
| 2026-02-11 | -17.6% | earnings | Seeking Alpha | Outset Medical Non-GAAP EPS of -$0.84 misses by $0.16, revenue of $28.9M in-line |
| 2026-02-11 | -17.6% | legal | SEC EDGAR | OM 8-K: 2.02 and (SEC Filing) |
| 2026-02-11 | -17.6% | news | Yahoo Finance | Outset Medical Reports Fourth Quarter and Full Year 2025 Financial Results - Yahoo Finance |
| 2026-02-11 | -17.6% | legal | Stock Titan | Dialysis device maker Outset cuts 2025 loss to $81.7M, gets FDA clearance - Stock Titan |
| 2025-01-08 | -15.0% | legal | SEC EDGAR | OM 8-K: 1.01, 1.02, 2.03, 5.03 (SEC Filing) |
| 2026-01-05 | +14.7% | news | Quiver Quantitative | Outset Medical, Inc. Announces Presentation at 44th Annual J.P. Morgan Healthcare Conference - Quiver Quantitative |
| 2024-05-08 | -14.3% | legal | SEC EDGAR | OM 8-K: 2.02, 5.02, 8.01 (SEC Filing) |
| 2025-02-13 | +14.2% | legal | Seeking Alpha | Outset Medical resolves FDA warning letter over Tablo products |
| 2025-02-13 | +14.2% | news | Seeking Alpha | Outset Medical plans $100M mixed shelf offering |
| 2025-02-13 | +14.2% | legal | MassDevice | Outset Medical resolves FDA warning letter - MassDevice |
| 2023-11-07 | -13.9% | legal | SEC EDGAR | OM 8-K: 2.02 and (SEC Filing) |
| 2023-08-02 | -12.9% | legal | SEC EDGAR | OM 8-K: 2.02 and (SEC Filing) |
| 2025-05-14 | +12.8% | legal | SEC EDGAR | OM 8-K: 5.02, 7.01 (SEC Filing) |
| 2022-05-04 | -12.6% | legal | SEC EDGAR | OM 8-K: 2.02 and (SEC Filing) |
| 2026-01-12 | +12.3% | legal | SEC EDGAR | OM 8-K: 2.02, 5.02, 7.01 (SEC Filing) |
| 2026-01-12 | +12.3% | earnings | Investing.com | Outset Medical stock beats Q4 sales estimates, reaches high end of 2025 guidance - Investing.com |
| 2026-01-12 | +12.3% | news | timothysykes.com | Outset Medical Shines with Dialysis Tech at JP Morgan Healthcare Conference - timothysykes.com |
| 2022-02-16 | +11.5% | legal | SEC EDGAR | OM 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-01-28 | -10.5% | legal | Yahoo Finance | OM Stock Gains on FDA Clearance for Next-Gen Tablo Dialysis System - Yahoo Finance |
| 2024-03-13 | -10.3% | legal | SEC EDGAR | OM 8-K: 5.02, 7.01 (SEC Filing) |
| 2026-01-26 | +10.2% | news | Quiver Quantitative | Outset Medical, Inc. to Announce Fourth Quarter and Full-Year 2025 Financial Results on February 11, 2026 - Quiver Quantitative |
| 2026-01-26 | +10.2% | news | Stock Titan | Dialysis device maker Outset Medical sets Feb. 11 results call - Stock Titan |
| 2026-01-26 | +10.2% | news | GlobeNewswire | Outset Medical to Report Fourth Quarter 2025 Financial Results on Wednesday, February 11, 2026 - GlobeNewswire |
| 2021-07-01 | -10.1% | legal | SEC EDGAR | OM 8-K: 2.02, 5.02, 7.01 (SEC Filing) |
| 2021-05-05 | -10.0% | legal | SEC EDGAR | OM 8-K: 2.02 and (SEC Filing) |
| 2023-05-03 | +9.7% | legal | SEC EDGAR | OM 8-K: 2.02 and (SEC Filing) |
| 2025-02-26 | -9.6% | legal | SEC EDGAR | OM 8-K: 3.01, 8.01 (SEC Filing) |
| 2024-01-08 | -8.8% | legal | SEC EDGAR | OM 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-01-23 | -8.5% | news | simplywall.st | Don't Ignore The Insider Selling In Outset Medical - simplywall.st |
| 2025-06-03 | +7.9% | executive | Seeking Alpha | Outset Medical appoints Renee Gaeta as CFO |
| 2025-06-03 | +7.9% | legal | SEC EDGAR | OM 8-K: 5.02, 5.07, 7.01 (SEC Filing) |
| 2025-06-03 | +7.9% | executive | GuruFocus | Outset Medical (OM) Welcomes Renee Gaeta as New CFO | OM Stock N - GuruFocus |
| 2023-02-13 | -7.6% | legal | SEC EDGAR | OM 8-K: 2.02, 5.02 (SEC Filing) |
| 2025-08-05 | -7.2% | earnings | Seeking Alpha | Outset Medical Q2 2025 Earnings Preview |
| 2022-11-04 | -7.1% | legal | SEC EDGAR | OM 8-K: 1.01, 2.03, 7.01 (SEC Filing) |
| 2022-07-22 | -6.2% | news | GlobeNewswire | Outset Medical, Inc. Shareholder Update: Robbins LLP - GlobeNewswire |
| 2025-02-19 | +5.9% | earnings | Seeking Alpha | Outset Medical Non-GAAP EPS of -$0.37 beats by $0.04, revenue of $29.5M beats by $1.03M |
| 2025-02-19 | +5.9% | legal | SEC EDGAR | OM 8-K: 2.02 and (SEC Filing) |
| 2025-02-19 | +5.9% | news | Stock Titan | Can Outset Medical's 11% Margin Leap and $50M Cash Burn Cut Signal a Turnaround? - Stock Titan |
| 2023-12-11 | -5.8% | legal | SEC EDGAR | OM 8-K: 1.01 and 2.03 (SEC Filing) |
| 2024-10-16 | -5.4% | legal | GlobeNewswire | Outset Medical (OM) Shares Down 94% Since Disclosing FDA - GlobeNewswire |
| 2025-09-23 | -5.4% | earnings | simplywall.st | Outset Medical (NASDAQ:OM) Has Debt But No Earnings; Should You Worry? - simplywall.st |
| 2026-01-21 | +5.2% | executive | Investing.com | Outset Medical chair and CEO Trigg sells $71k in stock - Investing.com |
| 2025-10-27 | -5.1% | news | Quiver Quantitative | Outset Medical, Inc. to Announce Third Quarter 2025 Financial Results on November 10, 2025 - Quiver Quantitative |
| 2025-09-22 | +4.8% | earnings | Seeking Alpha | Outset Medical: Revenue Trajectory Yet To Reflect Favorable Demand Tailwinds |
| 2025-09-22 | +4.8% | earnings | Seeking Alpha | Outset Medical: Revenue Trajectory Yet To Reflect Favorable Demand Tailwinds (NASDAQ:OM) - Seeking Alpha |
| 2025-02-20 | -4.8% | earnings | Seeking Alpha | Outset Medical projects $115M-$125M revenue in 2025 with focus on console growth and gross margin expansion |
| 2025-02-20 | -4.8% | earnings | Seeking Alpha | Outset Medical, Inc. (OM) Q4 2024 Earnings Call Transcript |
| 2025-02-20 | -4.8% | earnings | MassDevice | Outset Medical stock rises on Street-beating Q4, 2025 guidance - MassDevice |
| 2026-02-20 | -4.8% | earnings | Insider Monkey | Analyst Sentiment on Outset Medical (OM) Remains Strong Following Q4 Results |
| 2026-02-20 | -4.8% | news | Investing.com Nigeria | Outset Medical general counsel Brottem sells $9,520 in stock By Investing.com - Investing.com Nigeria |
| 2026-02-20 | -4.8% | earnings | Insider Monkey | Analyst Sentiment on Outset Medical (OM) Remains Strong Following Q4 Results - Insider Monkey |
| 2026-03-27 | +4.6% | news | Stock Titan | Vanguard realigns reporting; Outset Medical (OM) shows 0% stake - Stock Titan |
| 2026-04-16 | +4.5% | news | DirectorsTalk Interviews | Outset Medical, Inc. (OM) Stock Analysis: Exploring a Healthcare Play with 106.90% Potential Upside - DirectorsTalk Interviews |
| 2025-03-18 | -4.5% | legal | SEC EDGAR | OM 8-K: 8.01 and (SEC Filing) |
| 2025-03-18 | -4.5% | news | MassDevice | Outset Medical announces reverse stock split - MassDevice |
| 2023-01-09 | +4.5% | legal | SEC EDGAR | OM 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-01-08 | +4.4% | news | Investing.com | Nash, evp, sells Outset Medical (OM) shares worth $461 - Investing.com |
| 2026-03-23 | +4.3% | news | TMX Newsfile | Upcoming Meeting Dates - March 23, 2026 |
| 2026-02-14 | -4.3% | analyst | Simply Wall St. | US$10.50: That's What Analysts Think Outset Medical, Inc. (NASDAQ:OM) Is Worth After Its Latest Results |
| 2026-02-14 | -4.3% | analyst | Yahoo Finance | US$10.50: That's What Analysts Think Outset Medical, Inc. (NASDAQ:OM) Is Worth After Its Latest Results - Yahoo Finance |
| 2026-02-09 | +4.2% | analyst | Yahoo Finance | Stifel Lowers Price Target on Outset Medical, Inc. (OM) to $8, Maintains Buy Rating - Yahoo Finance |
| 2025-02-18 | +4.0% | earnings | Seeking Alpha | Outset Medical Q4 2024 Earnings Preview |
| 2025-07-16 | -3.6% | earnings | simplywall.st | Institutional investors may adopt severe steps after Outset Medical, Inc.'s (NASDAQ:OM) latest 14% drop adds to a year losses - simplywall.st |
| 2025-08-07 | -3.5% | earnings | Seeking Alpha | Outset Medical raises 2025 revenue guidance to $122M-$126M while advancing commercial transformation |
| 2025-08-07 | -3.5% | earnings | Seeking Alpha | Outset Medical, Inc. (OM) Q2 2025 Earnings Call Transcript |
| 2026-01-15 | -3.5% | news | Seeking Alpha | Outset Medical, Inc. (OM) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript |
| 2021-08-05 | -3.3% | legal | SEC EDGAR | OM 8-K: 2.02, 5.02, 7.01 (SEC Filing) |
| 2023-07-07 | -2.8% | legal | SEC EDGAR | OM 8-K: 8.01 and (SEC Filing) |
| 2026-04-20 | -2.6% | news | Cổng thông tin điện tử tỉnh Tây Ninh | Does Outset Medical (OM) stock justify its current price (Near Highs) 2026-04-20 - Momentum Picks - Cổng thông tin điện tử tỉnh Tây Ninh |
| 2026-04-20 | -2.6% | news | Cổng thông tin điện tử tỉnh Lào Cai | Does Outset Medical (OM) stock justify its current price (Near Highs) 2026-04-20 - Insider Info - Cổng thông tin điện tử tỉnh Lào Cai |
| 2025-03-11 | +2.4% | legal | SEC EDGAR | OM 8-K: 5.03, 8.01 (SEC Filing) |
| 2026-04-08 | +2.2% | news | GlobeNewswire | Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) |
| 2026-04-08 | +2.2% | news | Stock Titan | Outset Medical (OM) EVP granted 96,000 restricted stock units in equity award - Stock Titan |
| 2026-04-08 | +2.2% | news | Stock Titan | Outset Medical (OM) EVP Elliott Derick A. files initial Form 3 insider report - Stock Titan |
| 2026-04-08 | +2.2% | executive | Stock Titan | Outset Medical gives new commercial chief 96,000 stock units - Stock Titan |
| 2026-04-08 | +2.2% | news | GlobeNewswire | Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire |
| 2026-02-10 | -2.1% | earnings | Seeking Alpha | Outset Medical Q4 2025 Earnings Preview |
| 2026-04-06 | +1.7% | news | GlobeNewswire | Outset Medical Names Derick Elliott as Executive Vice President of Commercial |
| 2026-04-06 | +1.7% | news | Stock Titan | Outset brings in ex-Stryker leader as Tablo expands across hospitals - Stock Titan |
| 2026-04-06 | +1.7% | earnings | Cổng thông tin điện tử tỉnh Lào Cai | Should I Hold Outset Medical (OM) Stock Now | Price at $4.07, Up 1.50% - Post Earnings - Cổng thông tin điện tử tỉnh Lào Cai |
| 2026-04-06 | +1.7% | news | Cổng thông tin điện tử tỉnh Lào Cai | Should I Hold Outset Medical (OM) Stock Now | Price at $4.07, Up 1.50% - Social Momentum Signals - Cổng thông tin điện tử tỉnh Lào Cai |
| 2025-11-09 | -1.5% | earnings | Seeking Alpha | Outset Medical Q3 2025 Earnings Preview |
| 2025-09-10 | -1.4% | news | Seeking Alpha | Outset Medical, Inc. (OM) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript |
| 2026-04-13 | +1.4% | news | PR Newswire | Did Outset Medical, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - PR Newswire |
| 2021-05-24 | +1.3% | legal | SEC EDGAR | OM 8-K: 5.02, 7.01 (SEC Filing) |
| 2026-04-03 | +1.3% | news | Cổng thông tin điện tử tỉnh Lào Cai | OM Stock Analysis: Outset Medical Inc gains 4.43 pct to hit 4.01 price point - Cổng thông tin điện tử tỉnh Lào Cai |
| 2021-11-03 | -1.2% | legal | SEC EDGAR | OM 8-K: 2.02 and (SEC Filing) |
| 2025-04-16 | -1.2% | news | Seeking Alpha | Outset Medical: The Worst Is Over, But Execution Risk Remains High |
| 2025-04-16 | -1.2% | news | Seeking Alpha | Outset Medical: The Worst Is Over, But Execution Risk Remains High (NASDAQ:OM) - Seeking Alpha |
| 2026-04-14 | -1.1% | news | GlobeNewswire | Osisko Metals Announces Significant Increase in Mineral Resources at Gaspé Copper |
| 2023-10-03 | -1.1% | analyst | TradingView | OM Forecast — Price Target — Prediction for 2027 - TradingView |
| 2026-02-02 | +1.0% | news | simplywall.st | Outset Medical, Inc. (NASDAQ:OM) Held Back By Insufficient Growth Even After Shares Climb 35% - simplywall.st |
| 2026-01-13 | -0.9% | news | Yahoo Finance | Outset Medical (OM) Soars 22.2%: Is Further Upside Left in the Stock? - Yahoo Finance |
| 2025-08-14 | +0.8% | news | DirectorsTalk Interviews | Outset Medical, Inc. (OM) Stock Analysis: Exploring The 94.93% Potential Upside - DirectorsTalk Interviews |
| 2025-07-07 | +0.8% | news | Seeking Alpha | Why Outset Medical's Rock-Bottom Valuation Masks Explosive Growth |
| 2025-07-07 | +0.8% | news | Seeking Alpha | Why Outset Medical’s Rock-Bottom Valuation Masks Explosive Growth (NASDAQ:OM) - Seeking Alpha |
| 2026-01-27 | +0.7% | legal | SEC EDGAR | OM 8-K: 8.01 and (SEC Filing) |
| 2026-01-27 | +0.7% | legal | Investing.com | Outset Medical stock jumps after FDA clears next-gen Tablo platform - Investing.com |
| 2026-01-27 | +0.7% | legal | Stock Titan | FDA clears first dialysis system built to its toughest cybersecurity rules - Stock Titan |
| 2026-01-27 | +0.7% | legal | Investing.com | Outset Medical’s Tablo dialysis system meets FDA cybersecurity standards - Investing.com |
| 2022-09-10 | -0.7% | analyst | Zacks Investment Research | What is the current Price Target and Forecast for Outset Medical (OM) - Zacks Investment Research |
| 2026-04-09 | -0.5% | news | Cổng thông tin điện tử Tỉnh Sơn La | Is Outset Medical (OM) Stock Showing Strength | Price at $4.18, Down 0.48% - Community Momentum Stocks - Cổng thông tin điện tử Tỉnh Sơn La |
| 2026-04-09 | -0.5% | news | Xã Vĩnh Công | Is Outset Medical (OM) Stock Showing Strength | Price at $4.18, Down 0.48% - Community Momentum Stocks - Xã Vĩnh Công |
| 2022-04-25 | +0.4% | legal | SEC EDGAR | OM 8-K: 5.02, 7.01 (SEC Filing) |
| 2024-02-21 | -0.4% | legal | SEC EDGAR | OM 8-K: 2.02, 5.02 (SEC Filing) |
| 2026-04-18 | +0.2% | news | Cổng thông tin điện tử tỉnh Tây Ninh | Should investors consider Outset Medical (OM) stock right now (Technical Strength) 2026-04-18 - Swing Signals - Cổng thông tin điện tử tỉnh Tây Ninh |
| 2025-04-03 | +0.1% | news | Seeking Alpha | Stryker, Boston Scientific down as new tariffs impact medtech industry |
| 2025-08-06 | -0.1% | earnings | Seeking Alpha | Outset Medical Non-GAAP EPS of -$0.84 beats by $0.14, revenue of $31.4M beats by $1.99M |
| 2025-08-06 | -0.1% | legal | SEC EDGAR | OM 8-K: 2.02 and (SEC Filing) |
| 2025-05-06 | +0.1% | earnings | Seeking Alpha | Outset Medical Q1 2025 Earnings Preview |
| 2022-08-15 | -0.0% | news | GlobeNewswire | OUTSET MEDICAL, INC. (NASDAQ: OM) SHAREHOLDER CLASS ACTION - GlobeNewswire |
| 2025-06-25 | -0.0% | news | Yahoo Finance | Strength Seen in Outset Medical (OM): Can Its 15.0% Jump Turn into More Strength? - Yahoo Finance |
| 2026-04-24 | — | news | Stock Titan | Outset Medical (NASDAQ: OM) details 2026 meeting, board elections and exec pay - Stock Titan |